Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
0.00 (0.00%)
Inactive · Last trade price on Aug 31, 2026
Crinetics Pharmaceuticals Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Crinetics Pharmaceuticals stock had an average target of $85.
Price Target: $85 (+0.06%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Aug 11, 2026.
Analyst Ratings
The average analyst rating for Crinetics Pharmaceuticals stock from 9 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 13 | 13 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 14 | 14 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $85 | Hold | Reiterates | $85 | +0.06% | Aug 11, 2026 |
| UBS | UBS | Hold Downgrades $55 → $85 | Hold | Downgrades | $55 → $85 | +0.06% | Jul 28, 2026 |
| LifeSci Capital | LifeSci Capital | Hold Maintains $85 | Hold | Maintains | $85 | +0.06% | Jul 11, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Downgrades $83 → $85 | Hold | Downgrades | $83 → $85 | +0.06% | Jul 8, 2026 |
| Evercore ISI | Evercore ISI | Hold Downgrades $88 → $85 | Hold | Downgrades | $88 → $85 | +0.06% | Jul 8, 2026 |
Financial Forecast
Revenue This Year
79.84M
from 7.70M
Increased by 937.36%
Revenue Next Year
174.71M
from 79.84M
Increased by 118.83%
EPS This Year
-4.13
from -4.95
EPS Next Year
-4.03
from -4.13
EPS and Forward PE are based on non-GAAP adjusted numbers.